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Clinical Presentation
A 37-year-old woman had a urinary tract infection in July 2009
that was successfully treated by antibiotics but resulted in diarrhea.
She was placed on a probiotic diet and then became aware, during the
same month, of persistent and widespread, bilateral oral lesions. The
lesions on the tongue were somewhat painful and she was given
miracle mouthwash for symptomatic relief. She denied dysphagia,
odynophagia, neck swelling or masses, headaches, visual problems,
skin lesions, or otalgia. She also denied tobacco or alcohol abuse.
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Differential Diagnosis
Clinical examination revealed diffuse involvement of the oral
cavity with striated white lesions and areas of erosion and shallow
ulceration. A distinct reticular pattern was noted on the lower labial
mucosa. Erosive lichen planus was a prime consideration in this case
due to the distribution and clinical appearance of the lesions. Lichen
planus is a common condition of unknown etiology but believed to be
immune mediated, can affect both the skin and oral mucosa. It
develops primarily in middle-aged adults, and females are affected
more often than males. Lesions can present bilaterally on the posterior
buccal mucosa, but other oral sites such as the tongue, gingiva, lips,
and palate may also be involved. The lesions of erosive lichen planus
appear erythematous, often with central ulceration. Fine white striae
are classically observed around the periphery of the ulcers.
Several other immunologic and allergic conditions can present
with a clinical pattern similar to lichen planus including lupus
erythematosus, chronic ulcerative stomatitis, erythema multiforme and
graft-versus-host disease. The history of lesions developing while the
patient was on a probiotic diet raises suspicion for the possibility of an
allergic mucosal reaction to diet but it may also related to systemic
antibiotics. Probiotics are commonly used to treat antibiotic-associated
diarrhea which was the most probable scenario in the present case.
They are available in the form of foods and dietary supplements and
are not regulated by the Food and Drug Administration. Drug reactions
of the oral mucosa can have a variety of clinical appearances, including
lichenoid and lupus-like patterns. While probiotics have not been
specifically implicated in mucosal drug reactions, the nature and
composition of the patient’s diet were unknown. Resolution of lesions
would be expected with discontinuation of the potentially offending
agent.
Chronic ulcerative stomatitis (CUS) is a rare and recentlydescribed immune-mediated condition that also deserves consideration
in this case. Erosions and ulcerations of the tongue and buccal mucosa
are common. Irregular red and white areas typically surround the
ulcers, but defined striae may not be present. Similar to erosive lichen
planus, CUS may also present as a desquamative gingivitis. The
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disease predominates among females in the sixth decade [1] which is
a slightly older population when compared to lichen planus. Since CUS
usually responds best to Plaquenil, an incisional biopsy with direct
immunofluorescence is recommended for erosive lichenoid processes,
especially cases that are unresponsive to corticosteroids.
Lupus erythematosus (LE) is a common, multisystem,
immunologic condition that can present with a variety of oral
manifestations. Systemic lupus erythematosus (SLE) is the most
serious form of the disease due to the potential for kidney
involvement, which can eventually progress to renal failure.
Cutaneous, musculoskeletal, neurologic, and cardiac involvement are
also common. Oral lesions may be seen in up to 40% of patients [1].
The average age at diagnosis is 31 and women are affected 8–
10 times more often than men [1]. Chronic cutaneous lupus
erythematosus (CCLE) is a much less severe form of LE that is usually
limited to the skin and oral mucosa. A third form, subacute cutaneous
lupus erythematosus (SCLE), has clinical overlap between SLE and
CCLE. Oral lesions of LE may be lichenoid, granulomatous, or
nonspecific in appearance. Typical anatomic locations affected include
the buccal mucosa, palate, gingiva, and occasionally the lower lip.
Given the age and sex of the patient, as well as the clinical appearance
and distribution of the oral lesions, LE is another logical consideration
in the differential diagnosis of this case.

Diagnosis and Discussion
The patient in the current case was diagnosed with AML-M4
(acute myelogenous leukemia) in February of 2006 with normal
cytogenetics. The leukemia was initially treated with induction
chemotherapy followed by a HLA-matched BMT (human leukocyte
antigen matched bone marrow transplant) from a sibling donor in July
of 2006. She suffered from several opportunistic infections following
the transplant, including Coag (−) Staphylococcus bacteremia,
Acinetobacter bacteremia, AFB (acid fast bacillus) infection,
Pseudomonas aeruginosa and Proteus mirabilis. The patient achieved
remission following the transplant but developed graft-versus-host
disease (GVHD) limited to the upper gastrointestinal tract area which
was managed with photopheresis. She received re-induction
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chemotherapy with clofarabine and high dosage Ara-C after a relapse
in the summer of 2007, which was followed by consolidation therapy
with high dose Ara-C and idarubicin in September of 2007. This was
then followed by a match-unrelated stem cell transplant, treatment
with fludarabine and total body irradiation conditioning in November
2007. She again developed several opportunistic infections in July of
2009, including Coag (−) Staph bacteremia, cholecystitis, pancreatitis
secondary to Diazide diuretics, and herpes labialis. The herpes labialis
was initially resistant to Valtrex and acyclovir but was subsequently
responsive to cidofovir. In July 2009, she developed generalized oral
lesions with a lichenoid pattern on the gingiva, upper and lower labial
mucosa, bilateral buccal mucosa, right and left lateral tongue, and
posterior palate (Figs. 1, ,2).2). Her oral lesions were erosive in some
areas. The tongue, which also exhibited a reticular pattern, displayed
erosive areas and the patient experienced prominent glossodynia.
Cytology smears obtained for fungal identification, as well as fungal
cultures, were persistently negative. There was only limited relief with
topical antifungal and magic mouth rinses (comprised of 80 ml viscous
lidocaine 2%, 80 ml Mylanta and 80 ml diphenhydramine 12.5 mg per
5 ml elixir). A superficial tongue biopsy performed in September 2009
revealed parakeratosis, but was essentially inconclusive since the
sample did not contain any lamina propria. This was followed by a
biopsy of the lower lip mucosa which was diagnostic of the patient’s
condition, demonstrating mild keratosis with paucicellular interface
mucositis and marked epitheliotropism. Scattered apoptotic bodies
were detected at the basal layer of the epithelium. The lamina propria
supported a patchy mononuclear inflammatory cell infiltrate including
few macrophages. The histomorphological features were consistent
with graft-versus-host disease (Figs. 3, ,4).4). The patient was treated
with prednisolone syrup 15 mg/5 ml with instructions to rinse and
swallow for 2 min with 1 teaspoonful qid. The tongue symptoms
resolved and her lesions showed significant improvement.
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Fig. 1: Generalized leukoplakia and shallow ulcerations were noted on the
maxillary and mandibular gingiva (a–c) and hard palate (d) (Note the
reticular pattern seen in the palatal lesions)

Fig. 2: Striated white lesions and ulcerations were noted on the right and
left lateral tongue (a, b). The dorsal tongue (c) was affected at the anterior
and lateral aspects. A well-defined reticular pattern was also evident on the
lower lip mucosa (d)
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Fig. 3: Biopsy of the lower lip mucosa revealed a paucicellular interface
lichenoid inflammatory cell infiltrate. Periductal mononuclear inflammatory
cell infiltrate was also seen in the labial minor salivary glands. (arrow, insert)
(Hematoxylin and eosin stain original magnification 10×, insert original
magnification 20×)

Fig. 4: A high power view of the histomorphology of the lower lip biopsy
showing prominent epitheliotropism and several apoptotic bodies identified in
the basal layer of the epithelium (arrows). The lamina propria contained a
mononuclear inflammatory cell infiltrate and scattered macrophages
(Hematoxylin and eosin stain original magnification 40×)
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GVHD is serious complication that occurs in recipients of allogenic
hematopoietic stem cell transplantation, non-irradiated blood
transfusions, or transplacental lymphocyte transfusion to an
immunodeficient fetus. Bone marrow transplantation is a commonly
implemented therapy for the management of hematologic
malignancies, hemoglobinopathies, and selective autoimmune
disorders, and GVHD is considered to be a major limitation to the
success of the transplant procedure.
GVHD occurs as a result of the infusion of immunocompetent
donor T cells into the patient who is immunocompromised as a result
of reconditioning, total body irradiation, and high dose chemotherapy.
This results in a cascade of complex processes that include CD8+ and
CD4+ T cell differentiation and activation, recognition of major and
minor histocompatibility antigens, and the liberation of a number of
cytokines and interleukins in various stages including INF-α, IL1 and
IL2 among others. This ultimately results in the formation of natural
killer T cells and cytotoxic T cells, the latter being responsible for
damage of many of the host’s internal organs including the liver,
gastrointestinal tract, skin, and mucous membranes [2–5].
The acute type of GVHD is observed within the first 21 days to
3 months after BMT and is seen in approximately 75% of transplanted
patients. Acute GVHD is characterized by TH-1 type cytokine
production pattern with skin, liver, and gastrointestinal lesions, and is
caused by cytotoxic T cells and NK cells. In comparison, the chronic
form of GVHD is characterized by TH-2 type cytokine production with
systemic manifestations and autoimmune disease type features and
behavior. Chronic GVHD is seen in approximately 25% of BMT
survivors and it usually takes place 3 months after the BMT. Acute and
chronic GVHD also differ in their clinical and histomorphologic
presentation [3, 6–9]. Acute GVHD may initially present with
nonspecific signs and symptoms including fever, malaise, and faint
facial rash that rapidly spreads as a morbilliform maculopapular rash
to other areas, especially the palms and soles. This is accompanied by
watery diarrhea, jaundice, and hepatomegaly with elevation of liver
enzyme profiles. It can also present with more severe, toxic epidermal
necrolysis—like features. Chronic GVHD, on the other hand, is usually
characterized by systemic involvement of the eyes, esophagus, liver,
muscle, genitalia, skin, as well as the central and peripheral nervous
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systems. Rarely seen are features similar to lichen planus,
scleroderma and discoid lupus [2, 3, 5, 7, 9].
Tremendous overlap exists between the histomorphological
presentation of acute and chronic GVHD, demonstrating lichen planuslike features with focal or diffuse basal cell hydropic change, apoptotic
and dyskeratotic changes in all layers of epithelium, with closely
associated lymphocytes and cytoid bodies. A paucicellular,
predominantly chronic inflammatory cell infiltrate that may contain
patchy neutrophilic and eosinophilic components is seen in the lamina
propria. The acute lesions may also show, at least in early stages,
lichen planus-like features but more scarring in the later or
“sclerodermatous” phase of the disease [3, 5, 6].
With the advances in hematopoietic stem cell transplantation in
the last two decades, the validity of the criteria of separation between
chronic and acute GVHD was questioned since the separation was
more or less arbitrary. The acute form may persist beyond 3 months in
patients receiving reduced-intensity conditioning and the
manifestations of acute and chronic GVHD can be present
simultaneously. This generated the current consensus by the NIH that
clinical manifestations, not the time of onset of symptoms following
the transplant, is what determines if GVHD is acute or chronic [3, 5,
9].
Oral involvement is seen in 33–50% and 60–80% of acute and
chronic GVHD, respectively. Lesions may vary in clinical presentation,
spectrum, and severity, ranging from simple, punctate granular
erythema with mucosal atrophy to superficial, widespread ulceration to
reticular and erosive lichen planus-like and scleroderma—like features.
The oral lesions of GVHD may also appear as bulla and vesicles and
should therefore be distinguished from other entities that occur in this
region. The salivary gland tissue also exhibits Sjogrens syndrome-like
features histologically, such as periductal and perivascular lymphocytic
or mixed mononuclear inflammatory cell aggregates. Careful and
prolonged follow-up is necessary since there is a well-documented risk
of transformation to oral squamous cell carcinoma with more than 64
cases reported in the last 30 years [2, 5, 6, 9].
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In conclusion, the present case represents a well-documented
example of oral GVHD that occurred in a patient with AML. The exact
time of onset of these lesions was difficult to determine but her oral
complaints were brought to the attention of her clinicians after forty
8 months of the initial bone marrow transplant procedure. Currently,
her oral lesions remain well controlled with topical prednisone rinse
and she will also remain under careful clinical follow-up. Additional
biopsies will be taken in 6 months to exclude any possible dysplastic
changes which are well documented in oral GVHD lesions.
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